Strykervs.Zimmer Biomet
SYK vs ZBH · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Stryker is about 7.2× larger than Zimmer Biomet by market cap; Zimmer Biomet trades at the lower P/E (23.2 vs 38.0); year to date, Zimmer Biomet leads (+1.6% vs −6.2%).
Side by side
| SYK | ZBH | |
|---|---|---|
| Market cap | $127B | $17.6B |
| Price | $329.78 | $91.34 |
| Today | +0.8% | +2.4% |
| Return YTD | −6.2% | +1.6% |
| Return 1Y | −16.5% | −4.0% |
| P/E | 38.0 | 23.2 |
| P/S | 5.0 | 2.1 |
| P/B | 5.5 | 1.4 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
StrykerSYK
American medtech company focused on orthopaedics, surgical equipment and robot-assisted surgery (Mako).
Full SYK profile →More comparisons in Medtech & devices
See where SYK and ZBH sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →